HF
AGRX

HRT Financial’s Agile Therapeutics AGRX Stock Holding History

HRT Financial’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-249
Closed -$2K – 3661
2023
Q1 		$2K Buy
+249
New +$3.19K ﹤0.01% 2370
2022
Q2 		– Sell
-6
Closed -$2K – 4010
2022
Q1 		$2K Sell
6
-1
-14% -$638 ﹤0.01% 2990
2021
Q4 		$6K Sell
7
-49
-88% -$69.1K ﹤0.01% 3048
2021
Q3 		$106K Sell
56
-46
-45% -$104K ﹤0.01% 2885
2021
Q2 		$270K Buy
+102
New +$336K ﹤0.01% 2213
2021
Q1 		– Sell
-10
Closed -$55K – 3306
2020
Q4 		$55K Buy
+10
New +$58.9K ﹤0.01% 1691

Other funds holding AGRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's AGRX Position: Q2 2023 in Review

HRT Financial sold out of Agile Therapeutics (AGRX) in Q2 2023, closing a stake of 249 shares — an estimated $2K sold.

HRT Financial first reported a position in AGRX in Q4 2020 and held it in 6 quarters. The position peaked at $270K in Q2 2021. 16 funds tracked by Wall St. Rank hold AGRX as of Q2 2023.

  • HRT Financial reported no remaining Agile Therapeutics position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 249 Agile Therapeutics shares in Q2 2023, an estimated $2K.
  • HRT Financial first reported a position in Agile Therapeutics in Q4 2020 and held it in 6 quarters.
  • HRT Financial's Agile Therapeutics position peaked at $270K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.